Recruiting

MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(13 sites)

United States

City of Hope, Duarte, California

Emory Winship Cancer Center, Atlanta, Georgia

University of Chicago Cancer Center, Chicago, Illinois

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Dana Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts

Barbara Ann Karmanos Cancer Center, Detroit, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Washington University Medicine, St Louis, Missouri

Hackensack University Medical Center, Hackensack, New Jersey

Memorial Sloan Kettering Cancer Center, New York, New York

Mt. Sinai School of Medicine, New York, New York

Atrium Levine Cancer Institute, Charlotte, North Carolina

Tennessee Oncology, Nashville, Tennessee